Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea

Heart

Volumn 98, Issue 20, 2012, Pages 1518-1522

  Eckstein, Jens ^a   Potocki, Mihael ^a   Murray, Karsten ^a   Breidthardt, Tobias ^a   Ziller, Ronny ^a   Mosimann, Tamina ^a   Klima, Theresia ^a   Hoeller, Rebeca ^a   Moehring, Berit ^a   Sou, Seoung Mann ^a   Gimenez, Maria Rubini ^a   Morgenthaler, Nils G ^b   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; MID REGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ADULT; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; EMERGENCY WARD; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; UNIVERSITY HOSPITAL;

ACUTE DISEASE; AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; COHORT STUDIES; DYSPNEA; HEART FAILURE; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS;

EID: 84866614549     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302260     Document Type: Article

References (26)

1. Potocki M, Breidthardt T, Reichlin T, et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. J Intern Med 2010;267:119-29.
2. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. (Pubitemid 34764819)
3. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54. (Pubitemid 38364623)
4. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in an elderly population. J Intern Med 1997;242:307-11. (Pubitemid 27475603)
5. Silvet H, Young-Xu Y, Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003;92:1124-7. (Pubitemid 37329544)
6. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005;46:838-44. (Pubitemid 41224808)
7. Breidthardt T, Noveanu M, Cayir S, et al. The use of b-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. Int J Cardiol 2009;136:193-9.
8. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 2005;26:901-32. (Pubitemid 40725366)
9. Morgenthaler NG, Struck J, Thomas B, et al. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 2004;50:234-6. (Pubitemid 38125732)
10. Maisel A, Mueller C, Nowak R, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062-76.
11. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985;230:767-70.
12. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
13. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203. (Pubitemid 24203680)
14. Mueller C, Breidthardt T, Laule-Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007;137:4-12. (Pubitemid 46191225)
15. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003;41:571-9. (Pubitemid 36278374)
16. Daniels LB, Clopton P, Bhalla V, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 2006;151:999-1005.
17. Ala-Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogeneity has a major impact on the measurement of circulating n-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:1576-88. (Pubitemid 39121226)
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837-45.
19. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
20. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83. (Pubitemid 43855050)
21. Rienstra M, Van Gelder IC, Van den Berg MP, et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace 2006;8:482-7. (Pubitemid 43985484)
22. Roy D, Paillard F, Cassidy D, et al. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 1987;9:509-14. (Pubitemid 17024571)
23. Mookherjee S, Anderson G Jr, Smulyan H, et al. Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure. Am J Cardiol 1991;67:377-80.
24. Deftereos S, Giannopoulos G, Kossyvakis C, et al. Short-term fluctuations of plasma NT-proBNP levels in patients with new-onset atrial fibrillation: A way to assess time of onset? Heart 2010;96:1033-6.
25. Deftereos S, Giannopoulos G, Kossyvakis C, et al. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset. Heart 2011;97:914-17.
26. Yoshihara F, Nishikimi T, Sasako Y, et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure. J Am Coll Cardiol 2002;39:288-94. (Pubitemid 34084635)